Safety assessment of bone marrow derived MSC grown in platelet-rich plasma
The injection of endothelial progenitor cells and mononuclear cells derived from bone marrow at the ischemic region of peripheral artery disease patients is reported to be effective for therapeutic angiogenesis; however, these cell therapies require large amounts of bone marrow to obtain sufficient...
Main Authors: | Shoji Fukuda, Shotaro Hagiwara, Satsuki Fukuda, Ryo Yakabe, Hiroko Suzuki, Shigeharu G. Yabe, Techuan Chan, Hitoshi Okochi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-06-01
|
Series: | Regenerative Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352320415000115 |
Similar Items
-
Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton’s jelly-derived mesenchymal stem cells (WJ-MSC)
by: Gabriela Zavala, et al.
Published: (2017-09-01) -
Systematic Review—The Potential Implications of Different Platelet-Rich Plasma (PRP) Concentrations in Regenerative Medicine for Tissue Repair
by: Pietro Gentile, et al.
Published: (2020-08-01) -
The Effects of Leukocyte- and Platelet-Rich Plasma (L-Prp) and Pure Platelet-Rich Plasma (P-Prp) in a Rat Endometriosis Model
by: Ali Dogukan Anğın, et al.
Published: (2020-01-01) -
Impact of the Different Preparation Methods to Obtain Autologous Non-Activated Platelet-Rich Plasma (A-PRP) and Activated Platelet-Rich Plasma (AA-PRP) in Plastic Surgery: Wound Healing and Hair Regrowth Evaluation
by: Pietro Gentile, et al.
Published: (2020-01-01) -
Comparison of Hyclone and Biow: Effect to hMSC Proliferation, Morphology, and Osteogenic Differentiationest
by: Tania Saskianti, et al.
Published: (2013-01-01)